CE for Pharmacists: A Review of Pathophysiology and Treatment of Polycystic Ovary Syndrome (PCOS)
by Amy N. Bowman, 2023 PharmD Candidate, Taylor A. Shufelt, 2023 PharmD Candidate, Amy M. Wolff, 2024 PharmD Candidate, Dolyn Salm, 2024 PharmD Candidate, Joyce Hu, 2024 PharmD Candidate, Marina L. Maes, PharmD, BCPS, BCACP
Learning Objectives
Keywords: Female, Hyperandrogenism, Polycystic Ovary Syndrome, Androgens, Hirsutism, Insulin Resistance, Amenorrhea, Human Body, Menorrhagia, Menstruation, Metabolic Syndrome, Oligomenorrhea, Pharmacists, Transgender Persons, Luteinizing Hormone, Follicle Stimulating Hormone, Obesity, Acne Vulgaris, Alopecia, Patient Care, Testosterone, Infertility, Ovulation, Fertility, Oxidative Stress, Insulins
Download PDF
2022 September/October Table of Contents
Learning Objectives
- Recognize the most common characteristics and presentation of PCOS.
- Describe the hormonal imbalances involved in the pathophysiology of PCOS.
- Define commonly used terms that relate to ovulatory and menstrual dysfunction in patients with PCOS.
- Compare and contrast the most common manifestations of hyperandrogenism, oligomenorrhea, metabolic disorders, and fertility challenges in PCOS.
- Identify preferred treatment options for PCOS in relation to hyperandrogenism, oligomenorrhea, metabolic changes, and fertility.
Keywords: Female, Hyperandrogenism, Polycystic Ovary Syndrome, Androgens, Hirsutism, Insulin Resistance, Amenorrhea, Human Body, Menorrhagia, Menstruation, Metabolic Syndrome, Oligomenorrhea, Pharmacists, Transgender Persons, Luteinizing Hormone, Follicle Stimulating Hormone, Obesity, Acne Vulgaris, Alopecia, Patient Care, Testosterone, Infertility, Ovulation, Fertility, Oxidative Stress, Insulins
Download PDF
2022 September/October Table of Contents